Technology-based Company.

Engaged in advancing innovative solutions for large-scale market applications

Company Overview

Protecting Against Biological Threats

Polyrizon is a clinical development biotech company specializing on the development of innovative nasal gels to provide effective preventative treatment to protect against a wide cross section of viruses, including the COVID-19 virus, influenza, allergens, and other toxins. our proprietary Capture and Contain (“C&C”) hydrogel platform is delivered in the form of nasal sprays, and form a thin gel-based protective shield containment barrier in the nasal cavity that prevents viruses, bacteria, allergens, and other toxins to penetrate the nasal epithelial tissue

Facts and Figures

35.86%

Medigus’ holdings

12

Months to first
efficiency trial results

51%

Option to increase
holdings to